NCT07060430 Comparison of Kaltenborn Mobilization and Mobilization With Movement (MWM) in Wrist Hypomobility After Colle's Fracture
| NCT ID | NCT07060430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Colles Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-09-15 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to determine comparision of Kaltenborn Mobilization and Mobilization with Movement (MWM) in wrist Hpomobility after Colle's fracture.
Eligibility Criteria
Inclusion Criteria: * Both male and female participants (40-70 years old) Participants who will have diagnosed Colle's fracture and treated conservatively by plaster cast fixation and should referred from department of orthopedic surgery Patients group with post Colle's fractures stiffness Exclusion Criteria: * Patients having diagnosed Colle's fracture and treated with invasive procedure like K wiring, ORIF etc. * Patient with Neuromuscular injuries.(diagnosed) * Rheumatoid arthritis. * Patients with metacarpal fracture or compartment syndrome, non-union.(diagnosed)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07060430 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Colles Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07060430 currently recruiting?
Yes, NCT07060430 is actively recruiting participants. Contact the research team at tubaqaxmi0ct@gmail.com for enrollment information.
Where is the NCT07060430 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07060430 clinical trial?
NCT07060430 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.